Gennex Laboratories has informed that the exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August 11, 2022 for VAB Ventures.
The above information is a part of company’s filings submitted to BSE.